Given the preferential upregulation of MELK in cancers and recent experimental data suggesting the positive role of MELK on cancer cell growth, MELK has been recognized as a potential therapeutic target for brain, colorectal, lung, and ovarian cancers [29]. The gene discussed is MELK; the disease is ovarian cancer.